MARION JENKINS: Open Payments
NPI 1316988975 · HONEA PATH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,133 in 64 payments from 18 companies in 2025. Trend: 2023 $1,374 · 2024 $1,032 · 2025 $1,133
Food & beverage: $1,133
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $256 |
| ABBVIE INC. | 17 | $238 |
| AstraZeneca Pharmaceuticals LP | 2 | $138 |
| Abbott Laboratories | 4 | $70 |
| Novo Nordisk Inc | 4 | $65 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $57 |
| Exact Sciences Corporation | 2 | $36 |
| Edwards Lifesciences Corporation | 1 | $31 |
| Lilly USA, LLC | 2 | $29 |
Products named: VRAYLAR, NURTEC ODT, FARXIGA, ELIQUIS, XIFAXAN, PREVNAR 20, Symbravo, JARDIANCE.
Industry payments across SC — which companies pay providers there.
